Lv1
10 积分 2022-11-02 加入
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data
15天前
已完结
Bone Metastasis of Breast Cancer
15天前
已完结
Bone Metastasis of Breast Cancer
15天前
已关闭
Capivasertib en association au fulvestrant dans le cancer du sein localement avancé ou métastatique RH+ HER2– avec une altération de PIK3CA, AKT1 ou PTEN, après une première ligne d’hormonothérapie
2个月前
已关闭
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
2个月前
已完结
Pharmacokinetics, mass balance, and metabolism of [14C]FCN-437c, a selective and potent CDK4/6 inhibitor in humans
2个月前
已完结
How selective are clinical CDK4/6 inhibitors?
2个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
3个月前
已完结
Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
3个月前
已完结
Targeted therapy in TNBC: Exploring the role of antibody-drug conjugates with a focus on sacituzumab govitecan
3个月前
已完结
皖公网安备34019202002308
